Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PPP1R15A | O75807 | 1/20 | 0.38 |
| ▸ | MELK | Q14680 | 1/20 | 0.38 |
| ▸ | PPP1R15B | Q5SWA1 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379603 | 1.00 | POLB (0.50) | POLBGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL4697716 | 0.87 | MAPT (0.52) | POLBGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL4697826 | 0.76 | MAPT (0.54) | POLBKDM4ELMNAMAPTNPSR1 | |
| SCHEMBL914992 | 0.76 | MAPT (0.54) | POLBKDM4ELMNAMAPTNPSR1 | |
| SCHEMBL4946232 | 0.75 | POLB (0.57) | POLBKDM4ELMNAMAPTL3MBTL1 | |
| SCHEMBL4946236 | 0.75 | POLB (0.57) | POLBKDM4ELMNAMAPTL3MBTL1 | |
| SCHEMBL529833 | 0.75 | MAPT (0.55) | POLBKDM4ELMNAMAPTNPSR1 | |
| SCHEMBL530029 | 0.75 | MAPT (0.55) | POLBKDM4ELMNAMAPTNPSR1 | |
| SCHEMBL398854 | 0.74 | MAPT (0.48) | POLBKDM4ELMNAMAPTL3MBTL1 | |
| SCHEMBL398853 | 0.74 | MAPT (0.48) | POLBKDM4ELMNAMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008157537-A2 | COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS | IRONWOOD PHARMACEUTICALS, INC (US) | 2008-12-24 | — | — | WO | claimed |
| WO-2008124505-A2 | SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS | IRONWOOD PHARMACEUTICALS,INC. (US) | 2008-10-16 | — | — | WO | claimed |
| WO-2024086179-A1 | PYRIMIDINE SGC STIMULATORS | TISENTO THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024086182-A1 | TREATMENT OF MITOCHONDRIAL DISEASES WITH SGC STIMULATORS | TISENTO THERAPEUTICS INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| EP-4326268-A1 | TREATMENT OF CNS DISEASES WITH SGC STIMULATORS | Tisento Therapeutics Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4326722-A1 | SGC STIMULATORS | Tisento Therapeutics Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023018795-A1 | NEP INHIBITORS FOR THE TREATMENT OF LAMINITIS | CURTAILS LLC (US) | 2023-02-16 | — | — | WO | disclosed |
| WO-2022265984-A1 | USE OF NEP INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DISORDERS | CURTAILS LLC (US) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022225902-A1 | TREATMENT OF CNS DISEASES WITH SGC STIMULATORS | CYCLERION THERAPEUTICS, INC. (US) | 2022-10-27 | — | — | WO | disclosed |
| WO-2021202546-A1 | EARLY DRUG INTERVENTIONS TO REDUCE COVID-19 RELATED RESPIRATORY DISTRESS, NEED FOR VENTILATOR ASSISTANCE AND DEATH | CYCLERION THERAPEUTICS, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021195403-A1 | DEUTERATED SGC STIMULATORS | CYCLERION THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| EP-1668008-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-06-14 | — | — | EP | disclosed |
| WO-2006055542-A2 | DIURETIC COMPOUNDS COMPRISING HETEROCYCLIC NITRIC OXIDE DONOR GROUPS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006052899-A2 | NITROSATED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISORDERS | NITROMED, INC. (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006041855-A2 | COMPOSITIONS AND METHODS USING APOCYNIN COMPOUNDS AND NITRIC OXIDE DONORS | NITROMED, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| WO-2005107384-A2 | METHODS FOR TREATING BLOOD DISORDERS WITH NITRIC OXIDE DONOR COMPOUNDS | NITROMED, INC. (US) | 2005-11-17 | — | — | WO | disclosed |
| WO-2005070006-A2 | NITROSATED AND/OR NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005023183-A2 | NITROSATED AD NITROSYLATED DIURETIC COMPOUDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005023182-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005018561-A2 | NITROSATED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-03-03 | — | — | WO | disclosed |